Abiopharma

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Emily in Paris Season 5: Everything We Know So Far

New Form 11-K - TELEFLEX INC Filed: 2025-06-27 AccNo: 0000096943-25-000104 Size: 206 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033262 Size: 236 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033255 Size: 223 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033252 Size: 223 KB

New Form 11-K - Fresenius Medical Care AG Filed: 2025-06-27 AccNo: 0001104659-25-063533 Size: 253 KB

Zentek Provides Regulatory Update on ZenGUARD™ Enhanced Air Filters

New Form 11-K - METTLER TOLEDO INTERNATIONAL INC/ Filed: 2025-06-27 AccNo: 0001037646-25-000033 Size: 221 KB

New Form 6-K - BetterLife Pharma Inc. Filed: 2025-06-27 AccNo: 0001477932-25-004829 Size: 965 KB

New Form 1-A/A - AIBOTICS, INC. Filed: 2025-06-27 AccNo: 0001096906-25-001058 Size: 1 MB

SRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sarepta Class Action Lawsuit

New Form 8-K - AETHLON MEDICAL INC Filed: 2025-06-27 AccNo: 0001683168-25-004784 Size: 303 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits